| RS886042653 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal dominant 37 |
| RS886042654 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS886042657 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS886042660 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS886042662 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
EEG abnormality, Exaggerated startle response |
| RS886042663 |
ZIC3
|
Health Risk |
Pathogenic |
— |
| RS886042667 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042668 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042672 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS886042676 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS886042677 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS886042679 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS886042680 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS886042681 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042682 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS886042684 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042688 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042691 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886042694 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS886042700 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042705 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042718 |
SHOX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042722 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS886042725 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886042727 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS886042729 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS886042730 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042733 |
DNAH11
|
Health Risk |
Likely pathogenic |
— |
| RS886042734 |
CEP290
|
Health Risk |
Pathogenic |
— |
| RS886042735 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS886042736 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS886042737 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042740 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS886042741 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS886042742 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS886042743 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS886042745 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042747 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042748 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1B, Bethlem myopathy 1B |
| RS886042749 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS886042751 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886042756 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS886042757 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS886042758 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042759 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886042761 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS886042766 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS886042771 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS886042773 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042778 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Dilated cardiomyopathy 1X |
| RS886042781 |
PDHX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042782 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042792 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS886042795 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042799 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS886042805 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS886042806 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS886042807 |
RPE65
|
Health Risk |
Pathogenic |
— |
| RS886042810 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886042811 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS886042819 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Cardiovascular phenotype |
| RS886042820 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS886042823 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042825 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042826 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS886042827 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042828 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042830 |
SBF2
|
Health Risk |
Likely pathogenic |
— |
| RS886042831 |
NAGS
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperammonemia, type III |
| RS886042833 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
EIF2AK3-related disorder, Inborn genetic diseases |
| RS886042834 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystinuria, Inborn genetic diseases |
| RS886042836 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042838 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS886042839 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042840 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS886042842 |
BCOR
|
Health Risk |
Pathogenic |
Glioblastoma, Inborn genetic diseases |
| RS886042845 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS886042846 |
NRXN1
|
Health Risk |
Pathogenic |
— |
| RS886042847 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS886042848 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a NOTCH2 point mutation, Hajdu-Cheney syndrome |
| RS886042849 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia congenita, Platyspondylic dysplasia |
| RS886042850 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS886042851 |
NPR2
|
Health Risk |
Likely pathogenic |
— |
| RS886042854 |
MMP13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042856 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS886042861 |
VAMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS886042862 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS886042866 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886042872 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886042875 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042877 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS886042878 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042879 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS886042880 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042881 |
NEU1
|
Health Risk |
Likely pathogenic |
— |
| RS886042883 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042885 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042889 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS886042895 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS886042897 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |